BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Azziz R. Polycystic Ovary Syndrome. Obstet Gynecol. 2018;132:321-336. [PMID: 29995717 DOI: 10.1097/aog.0000000000002698] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia LY, Feng JX, Li JL, Liu FY, Xie LZ, Luo SJ, Han FJ. The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism. Evid Based Complement Alternat Med 2021;2021:5555315. [PMID: 33727939 DOI: 10.1155/2021/5555315] [Reference Citation Analysis]
2 Lin H, Liu M, Zhong D, Ng EHY, Liu J, Li J, Shi Y, Zhang C, Wen X, Mai Z, Ou M, Ma H. The Prevalence and Factors Associated With Anxiety-Like and Depression-Like Behaviors in Women With Polycystic Ovary Syndrome. Front Psychiatry 2021;12:709674. [PMID: 34744814 DOI: 10.3389/fpsyt.2021.709674] [Reference Citation Analysis]
3 Aversa A, La Vignera S, Rago R, Gambineri A, Nappi RE, Calogero AE, Ferlin A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne) 2020;11:516. [PMID: 32849300 DOI: 10.3389/fendo.2020.00516] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Kelley AS, Puttabyatappa M, Ciarelli JN, Zeng L, Smith YR, Lieberman R, Pennathur S, Padmanabhan V. Prenatal Testosterone Excess Disrupts Placental Function in a Sheep Model of Polycystic Ovary Syndrome. Endocrinology 2019;160:2663-72. [PMID: 31436841 DOI: 10.1210/en.2019-00386] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ke Y, Hu J, Zhu Y, Wang Y, Chen S, Liu S. Correlation Between Circulating Adropin Levels and Patients with PCOS: An Updated Systematic Review and Meta-analysis. Reprod Sci 2022. [PMID: 35015289 DOI: 10.1007/s43032-022-00841-1] [Reference Citation Analysis]
6 Nayak PK, Mitra S, Sahoo J, Mahapatra E, Agrawal S, Lone Z. Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients. J Family Med Prim Care 2020;9:147-50. [PMID: 32110581 DOI: 10.4103/jfmpc.jfmpc_654_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients 2019;11:E188. [PMID: 30658483 DOI: 10.3390/nu11010188] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
8 Falahatian S, Haddad R, Pakravan N. Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome. J Ovarian Res 2022;15:4. [PMID: 34991678 DOI: 10.1186/s13048-021-00926-6] [Reference Citation Analysis]
9 Duan X, Zhou M, Zhou G, Zhu Q, Li W. Effect of metformin on adiponectin in PCOS: A meta-analysis and a systematic review. Eur J Obstet Gynecol Reprod Biol 2021;267:61-7. [PMID: 34717078 DOI: 10.1016/j.ejogrb.2021.10.022] [Reference Citation Analysis]
10 Xu W, Tang M, Wang J, Wang L. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:4086864. [PMID: 32148541 DOI: 10.1155/2020/4086864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Li X, Zhou L, Peng G, Liao M, Zhang L, Hu H, Long L, Tang X, Qu H, Shao J, Zheng H, Long M. Pituitary P62 deficiency leads to female infertility by impairing luteinizing hormone production. Exp Mol Med 2021;53:1238-49. [PMID: 34453106 DOI: 10.1038/s12276-021-00661-4] [Reference Citation Analysis]
12 Andrés S, Madsen O, Montero O, Martín A, Giráldez FJ. The Role of Feed Restriction on DNA Methylation, Feed Efficiency, Metabolome, Biochemical Profile, and Progesterone Patterns in the Female Filial Generation (F1) Obtained From Early Feed Restricted Ewes (F0). Front Physiol 2021;12:779054. [PMID: 35024036 DOI: 10.3389/fphys.2021.779054] [Reference Citation Analysis]
13 Wang W, Ge L, Zhang L, Liu L, Zhang X, Ma X. MicroRNA-16 represses granulosa cell proliferation in polycystic ovarian syndrome through inhibition of the PI3K/Akt pathway by downregulation of Apelin13. Hum Fertil (Camb) 2021;:1-11. [PMID: 34854361 DOI: 10.1080/14647273.2021.1998661] [Reference Citation Analysis]
14 Zhou L, Han X, Li W, Wang N, Yao L, Zhao Y, Zhang L. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2. Reprod Sci 2021. [PMID: 34254281 DOI: 10.1007/s43032-021-00664-6] [Reference Citation Analysis]
15 Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 12.7] [Reference Citation Analysis]
16 Harris AA, Kabadi UM. MORE THAN MEETS THE EYE IN A PATIENT WITH PCOS: ANDROGEN-SECRETING GRANULOSA CELL OVARIAN TUMOR IN A VIRILIZED WOMAN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS). AACE Clin Case Rep 2020;6:e170-3. [PMID: 32734001 DOI: 10.4158/ACCR-2019-0576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Seow KM, Chang YW, Chen KH, Juan CC, Huang CY, Lin LT, Tsui KH, Chen YJ, Lee WL, Wang PH. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome. Int J Mol Sci 2020;21:E8147. [PMID: 33142702 DOI: 10.3390/ijms21218147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Moradi A, Ghasemian F, Mashayekhi F. The reaggregation of normal granulosa-cumulus cells and mouse oocytes with polycystic ovarian syndrome in vitro: An experimental study. Int J Reprod Biomed 2021;19:987-96. [PMID: 34977456 DOI: 10.18502/ijrm.v19i11.9914] [Reference Citation Analysis]
19 Xu XL, Deng SL, Lian ZX, Yu K. Estrogen Receptors in Polycystic Ovary Syndrome. Cells 2021;10:459. [PMID: 33669960 DOI: 10.3390/cells10020459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bedrick BS, Eskew AM, Chavarro JE, Jungheim ES. Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome. Womens Health Rep (New Rochelle) 2020;1:566-73. [PMID: 33786523 DOI: 10.1089/whr.2020.0073] [Reference Citation Analysis]
21 Velazquez ME, Millan AL, Rojo M, Abruzzese GA, Cocucci SE, Iglesias Molli AE, Frechtel GD, Motta AB, Cerrone GE. Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:604215. [PMID: 34054718 DOI: 10.3389/fendo.2021.604215] [Reference Citation Analysis]
22 Kim MS, Fraga NR, Minaeian N, Geffner ME. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia. Front Endocrinol 2022;13:848274. [DOI: 10.3389/fendo.2022.848274] [Reference Citation Analysis]
23 Hsieh Y, Yang P, Chen M. Metabolic Syndrome in Polycystic Ovary Syndrome. FandR 2021;03:125-35. [DOI: 10.1142/s2661318221500158] [Reference Citation Analysis]
24 Chen Z, Tan J, Wang H, Zheng B, Liu J, Hao G, Guo Z, Sun Z, Yu Q. A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome? Front Endocrinol 2022;13:813188. [DOI: 10.3389/fendo.2022.813188] [Reference Citation Analysis]
25 Chen C, Wang WF, Yang GL, Guo C. Association Between Angiotensin-Converting Enzyme Gene I/D Polymorphism and Polycystic Ovary Syndrome Susceptibility: a Meta-analysis. Reprod Sci 2021. [PMID: 34773203 DOI: 10.1007/s43032-021-00786-x] [Reference Citation Analysis]
26 Ilias I, Goulas S, Zabuliene L. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World J Clin Cases 2021; 9(12): 2711-2720 [PMID: 33969054 DOI: 10.12998/wjcc.v9.i12.2711] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zimmerman LD, Setton R, Pereira N, Rosenwaks Z. Contemporary Management of Polycystic Ovarian Syndrome. Clin Obstet Gynecol 2019;62:271-81. [PMID: 30994482 DOI: 10.1097/GRF.0000000000000449] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Allahveisi A, Yousefian E, Rezaie MJ, Nikkhoo B. COMPARISON OF MORPHOMETRIC AND MORPHOLOGY OOCYTES AFTER IN VITRO MATURATION BETWEEN HEALTHY WOMEN AND PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME. Acta Endocrinol (Buchar) 2019;15:295-300. [PMID: 32010346 DOI: 10.4183/aeb.2019.295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences. J Clin Endocrinol Metab 2021:dgab613. [PMID: 34546364 DOI: 10.1210/clinem/dgab613] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wei L, Wu F, Zhang J, Li J, Yang D, Wen G, Koundal D. Evaluation of Endocrine and Metabolic Changes in Polycystic Ovary Syndrome by Ultrasonic Imaging Features under an Intelligent Algorithm. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1411943] [Reference Citation Analysis]
31 Liu Y, Ding J, Tan X, Shen Y, Xu L, Li T, Ma W, Wu J. GPR120 agonist ameliorated insulin resistance and improved ovarian function. Zygote 2021;:1-6. [PMID: 34879886 DOI: 10.1017/S0967199421000873] [Reference Citation Analysis]
32 Yosri MM, Hamada HA, Yousef AM. Effect of visceral manipulation on menstrual complaints in women with polycystic ovarian syndrome. J Osteopath Med 2022. [PMID: 35488711 DOI: 10.1515/jom-2021-0255] [Reference Citation Analysis]
33 Duan J, Cai H, Huang Y, Shi L. SNAI2-Induced CircMTO1 Promotes Cell Proliferation and Inhibits Apoptosis Through the miR-320b/MCL1 Axis in Human Granulosa-Like Tumor Cells. Front Genet 2021;12:689916. [PMID: 34413875 DOI: 10.3389/fgene.2021.689916] [Reference Citation Analysis]
34 Du C, Chen X. Transcriptome Profiling of Oocytes at the Germinal Vesicle Stage from Women from Mongolia with Polycystic Ovary Syndrome. Int J Gen Med 2021;14:4469-78. [PMID: 34413674 DOI: 10.2147/IJGM.S321853] [Reference Citation Analysis]
35 Bai X, Zheng L, Li D, Xu Y. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol 2021;19:122. [PMID: 34362377 DOI: 10.1186/s12958-021-00802-4] [Reference Citation Analysis]
36 Paalanne M, Vääräsmäki M, Mustaniemi S, Tikanmäki M, Wehkalampi K, Matinolli HM, Eriksson J, Järvelin MR, Morin-Papunen L, Kajantie E. Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm. Eur J Endocrinol 2021;185:279-88. [PMID: 34081616 DOI: 10.1530/EJE-20-1462] [Reference Citation Analysis]
37 Chen F, Lu J, Guo R, Mei C, Guo B, Li W, Tsigkou A, Shi Z. Rectifying cow infertility under heat stress by immunization against inhibin and supplementation of progesterone. Domestic Animal Endocrinology 2022. [DOI: 10.1016/j.domaniend.2022.106726] [Reference Citation Analysis]
38 Qian D, Wang Z, Cheng Y, Luo R, Ge S, Xu G. Early Menopause May Associate With a Higher Risk of CKD and All-Cause Mortality in Postmenopausal Women: An Analysis of NHANES, 1999–2014. Front Med 2022;9:823835. [DOI: 10.3389/fmed.2022.823835] [Reference Citation Analysis]
39 Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility. Biomedicines 2019;7:E5. [PMID: 30621143 DOI: 10.3390/biomedicines7010005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
40 Zhu Y, Li Y, Liu M, Hu X, Zhu H. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis. Front Endocrinol (Lausanne) 2020;11:575. [PMID: 32973686 DOI: 10.3389/fendo.2020.00575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Krysiak R, Basiak M, Okopień B. Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia. Molecules 2021;26:2844. [PMID: 34064815 DOI: 10.3390/molecules26102844] [Reference Citation Analysis]
42 Kabakchieva P, Georgiev T, Gateva A, Hristova J, Kamenov Z. Polycystic ovary syndrome and (pre)osteoarthritis: assessing the link between hyperandrogenism in young women and cartilage oligomeric matrix protein as a marker of cartilage breakdown. Clin Rheumatol 2021. [PMID: 33948768 DOI: 10.1007/s10067-021-05753-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Szymanska M, Shrestha K, Girsh E, Harlev A, Eisenberg I, Imbar T, Meidan R. Reduced Endothelin-2 and Hypoxic Signaling Pathways in Granulosa-Lutein Cells of PCOS Women. Int J Mol Sci 2021;22:8216. [PMID: 34360981 DOI: 10.3390/ijms22158216] [Reference Citation Analysis]
44 Abdelazeem B, Abbas KS, Shehata J, Baral N, Banour S, Hassan M. The effects of curcumin as dietary supplement for patients with polycystic ovary syndrome: An updated systematic review and meta-analysis of randomized clinical trials. Phytother Res 2021. [PMID: 34517426 DOI: 10.1002/ptr.7274] [Reference Citation Analysis]
45 Huddleston HG, Dokras A. Diagnosis and Treatment of Polycystic Ovary Syndrome. JAMA 2022;327:274-5. [PMID: 35040896 DOI: 10.1001/jama.2021.23769] [Reference Citation Analysis]
46 Medina-Laver Y, Rodríguez-Varela C, Salsano S, Labarta E, Domínguez F. What Do We Know about Classical and Non-Classical Progesterone Receptors in the Human Female Reproductive Tract? A Review. Int J Mol Sci 2021;22:11278. [PMID: 34681937 DOI: 10.3390/ijms222011278] [Reference Citation Analysis]
47 Zhou G, Gu Y, Zhou F, Zhang H, Zhang M, Zhang G, Wu L, Hua K, Ding J. Adipocytes-Derived Extracellular Vesicle-miR-26b Promotes Apoptosis of Cumulus Cells and Induces Polycystic Ovary Syndrome. Front Endocrinol 2022;12:789939. [DOI: 10.3389/fendo.2021.789939] [Reference Citation Analysis]
48 Mahboobifard F, Rahmati M, Niknam A, Rojhani E, Momenan AA, Azizi F, Ramezani Tehrani F. Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study. Arch Med Res 2021:S0188-4409(21)00221-6. [PMID: 34823887 DOI: 10.1016/j.arcmed.2021.11.001] [Reference Citation Analysis]
49 Wu W, Duan C, Lv H, Song J, Cai W, Fu K, Xu J. MiR-let-7d-3p inhibits granulosa cell proliferation by targeting TLR4 in polycystic ovary syndrome. Reprod Toxicol 2021;106:61-8. [PMID: 34655744 DOI: 10.1016/j.reprotox.2021.10.003] [Reference Citation Analysis]
50 Ni Z, Mei S, You S, Lin Y, Cheng W, Zhou L, Kuang Y, Yu C. Adverse Effects of Polycystic Ovarian Syndrome on Pregnancy Outcomes in Women With Frozen-Thawed Embryo Transfer: Propensity Score-Matched Study. Front Endocrinol 2022;13:878853. [DOI: 10.3389/fendo.2022.878853] [Reference Citation Analysis]
51 Qian H, Xu W, Cui L, Wang R, Wang J, Tang M, Wei M, Wang L. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial. Trials 2021;22:781. [PMID: 34743745 DOI: 10.1186/s13063-021-05770-z] [Reference Citation Analysis]
52 Zhao H, Zhang Y, Ye J, Wei H, Huang Z, Ning X, Fu X. A Comparative Study on Insulin Secretion, Insulin Resistance and Thyroid Function in Patients with Polycystic Ovary Syndrome with and without Hashimoto's Thyroiditis. Diabetes Metab Syndr Obes 2021;14:1817-21. [PMID: 33953581 DOI: 10.2147/DMSO.S300015] [Reference Citation Analysis]
53 Notaro ALG, Neto FTL. The use of metformin in women with polycystic ovary syndrome: an updated review. J Assist Reprod Genet. [DOI: 10.1007/s10815-022-02429-9] [Reference Citation Analysis]
54 Feng W, Zhang Y, Pan Y, Zhang Y, Liu M, Huang Y, Xiao Y, Mo W, Jiao J, Wang X, Tian D, Yang L, Ma Y. Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women. Reprod Biol Endocrinol 2021;19:5. [PMID: 33407572 DOI: 10.1186/s12958-020-00688-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Khan A, Karim N, Ainuddin JA, Fahim MF. Polycystic Ovarian Syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters. Pak J Med Sci 2019;35:1227-32. [PMID: 31488983 DOI: 10.12669/pjms.35.5.742] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
56 Link DG. Obesity in Women: Paying a High Price. Nurs Clin North Am 2021;56:609-17. [PMID: 34749899 DOI: 10.1016/j.cnur.2021.07.005] [Reference Citation Analysis]
57 Cho IY, Chang Y, Kang JH, Kim Y, Sung E, Shin H, Wild SH, Byrne CD, Ryu S. Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab 2022;107:e2309-17. [PMID: 35238939 DOI: 10.1210/clinem/dgac068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Brennan KM, Kroener LL, Chazenbalk GD, Dumesic DA. Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health. Obstet Gynecol Surv 2019;74:223-31. [PMID: 31344250 DOI: 10.1097/OGX.0000000000000661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
59 Kelley AS, Smith YR, Padmanabhan V. A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2019;104:5299-315. [PMID: 31393571 DOI: 10.1210/jc.2019-00383] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
60 Wu CH, Chiu LT, Chang YJ, Lee CI, Lee MS, Lee TH, Wei JC. Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study. Front Med (Lausanne) 2020;7:574651. [PMID: 33072787 DOI: 10.3389/fmed.2020.574651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Szeliga A, Rudnicka E, Maciejewska-jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R, Meczekalski B. Neuroendocrine Determinants of Polycystic Ovary Syndrome. IJERPH 2022;19:3089. [DOI: 10.3390/ijerph19053089] [Reference Citation Analysis]
62 Zhang J, Bao Y, Zhou X, Zheng L. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol 2019;17:67. [PMID: 31420039 DOI: 10.1186/s12958-019-0509-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
63 Silva IS, Ferreira CN, Costa LBX, Sóter MO, Carvalho LML, de C Albuquerque J, Sales MF, Candido AL, Reis FM, Veloso AA, Gomes KB. Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models. J Endocrinol Invest 2021. [PMID: 34524677 DOI: 10.1007/s40618-021-01672-8] [Reference Citation Analysis]
64 Mahboobifard F, Rahmati M, Amiri M, Azizi F, Ramezani Tehrani F. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study. Adv Med Sci 2022;67:79-86. [PMID: 34998115 DOI: 10.1016/j.advms.2021.12.003] [Reference Citation Analysis]
65 Liu X, Wang L, Zuo X, Li C, Teng Y. Women with PCOS with a History of Early Pregnancy Loss Show a Higher Risk of Gestational Diabetes Mellitus. Int J Gen Med 2021;14:6409-16. [PMID: 34675609 DOI: 10.2147/IJGM.S334666] [Reference Citation Analysis]
66 Kabakchieva P, Gateva A, Hristova J, Georgiev T, Kamenov Z. Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes. Cannabis Cannabinoid Res 2022. [PMID: 35235418 DOI: 10.1089/can.2021.0183] [Reference Citation Analysis]
67 Lu C, Wang H, Yang J, Zhang X, Chen Y, Feng R, Qian Y. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome. Front Cell Infect Microbiol 2021;11:755741. [PMID: 34804995 DOI: 10.3389/fcimb.2021.755741] [Reference Citation Analysis]
68 Reyes-Muñoz E, Sathyapalan T, Rossetti P, Shah M, Long M, Buscema M, Valenti G, La Rosa VL, Cianci S, Vitale SG. Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review. Adv Ther 2018;35:1805-15. [PMID: 30311070 DOI: 10.1007/s12325-018-0810-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
69 Di Stasi V, Maseroli E, Rastrelli G, Scavello I, Cipriani S, Todisco T, Marchiani S, Sorbi F, Fambrini M, Petraglia F, Maggi M, Vignozzi L. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Front Endocrinol (Lausanne). 2021;12:641446. [PMID: 33854482 DOI: 10.3389/fendo.2021.641446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, Zhang Y, Ma C, Ding J, Hua K. Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Front Endocrinol 2022;13:808508. [DOI: 10.3389/fendo.2022.808508] [Reference Citation Analysis]